Trials / Completed
CompletedNCT06111690
Blood Flow Restriction Training in Individuals Awaiting Total Knee Replacement
Feasibility of Prehabilitation Blood-flow Restriction Training in Individuals Awaiting Total Knee Replacement.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The aim is to demonstrate that preoperative exercises (pre-habilitation) using blood-flow restriction training (BFRT) is safe, well tolerated, improves muscle function, decreases functional limitation, and increases physical activity in older adults awaiting total knee replacement (TKR).
Detailed description
Twenty individuals ≥60 years old awaiting TKR due to diagnosis of end-stage knee osteoarthritis who meet the inclusion/exclusion criteria will be invited to participate in a 6 weeks of low-intensity BFRT prehabilitation. We will assess muscle functional (i.e., cross-sectional area and intramuscular fatty content) using computerized tomography, quadriceps muscle strength using an isokinetic dynamometer, a battery of performance-based physical function, self-reported physical function and quality of life, and biomarkers of inflammation using blood serum. Feasibility assessment will be done by looking at safety (i.e., adverse events), compliance, and attrition rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood Flow Restriction Training (BFRT) | Participants will be performing low-resistance exercise with (BFRT). Intervention will start at least seven days after initial evaluation, so it does not influence measures of real-time physical activity. We will use a log to register exercise completion and to record bilateral knee pain before, during and after each intervention session |
Timeline
- Start date
- 2022-09-23
- Primary completion
- 2024-10-02
- Completion
- 2024-12-02
- First posted
- 2023-11-01
- Last updated
- 2026-03-24
- Results posted
- 2026-03-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06111690. Inclusion in this directory is not an endorsement.